The combined antenatal corticosteroids and vitamin K therapy for preventing periventricular-intraventricular hemorrhage in premature newborns less than 35 weeks gestation
- PMID: 16751657
- DOI: 10.1093/tropej/fml028
The combined antenatal corticosteroids and vitamin K therapy for preventing periventricular-intraventricular hemorrhage in premature newborns less than 35 weeks gestation
Abstract
We prospectively evaluated whether combined antenatal corticosteroid and vitamin K administration have any benefit, over and above that of corticosteroid or vitamin K used alone, in reducing the frequency and the degree of PIVH in premature newborns less than 35 weeks' gestation. All of these 280 pregnant women were randomly allocated into five groups according to the in-patient sequence. Group A (vitamin K1 group) including 38 pregnant women (40 newborns) received antenatal intramuscular or intravenously injection of vitamin K1 10 mg per day for 2-7 days. Group B (single dose corticosteroid group) including 57 pregnant women (63 newborns) received antenatal intramuscular or intravenously injection of dexamethasone 10 mg per day for 1 day. Group C (two dose corticosteroid group) including 62 pregnant women (70 newborns) received antenatal intramuscular or intravenously injection of dexamethasone 10 mg per day for 2 days. Group D (combined using dexamethasone and vitamin K1) including 41 pregnant women (44 newborns) received dexamethasone 10 mg per day for 1 day and vitamin K110 mg per day for 2-7 days. Control group, including 82 pregnant women (87 newborns) were received neither dexamethasone nor vitamin K1 injection. The results showed PIVH was diagnosed in 17 of 40 (42.5%) in Group A, 34 of 63 (54.0%) in Group B, 36 of 70 (51.4%) in Group C, 14 of 44 (31.8%) in Group D, and 57 of 87 (65.2%) in control infants (p = 0.004). More infants in the control group had grade III or IV intracranial hemorrhage after birth (p = 0.049). After antenatal supplement of dexamethasone and vitamin K1, both the total incidence of PIVH and the frequency of severe PIVH decreased significantly. The total and severe incidence of PIVH in Group B (single doses dexamethasone) and Group C (two courses dexamethasone) there were no significant difference. It showed that after antenatal supplement of dexamethasone and vitamin K1, both the total incidence of PIVH and the frequency of severe PIVH decreased significantly, and combined antenatal corticosteroid and vitamin K administration have much benefit, over and above that of corticosteroid or vitamin K used alone.
Similar articles
-
Maternal antenatal administration of vitamin K1 results in increasing the activities of vitamin K-dependent coagulation factors in umbilical blood and in decreasing the incidence rate of periventricular-intraventricular hemorrhage in premature infants.J Perinat Med. 2006;34(2):173-6. doi: 10.1515/JPM.2006.031. J Perinat Med. 2006. PMID: 16519625 Clinical Trial.
-
[Level of vitamin K-dependent coagulation factors in premature infants and the influence of maternal antenatal administration of vitamin K1 on their activity].Zhonghua Er Ke Za Zhi. 2005 Dec;43(12):908-10. Zhonghua Er Ke Za Zhi. 2005. PMID: 16412352 Clinical Trial. Chinese.
-
Maternal administration of vitamin K does not improve the coagulation profile of preterm infants.Pediatrics. 1989 Dec;84(6):1045-50. Pediatrics. 1989. PMID: 2587133 Clinical Trial.
-
Antenatal hormone therapy for improving the outcome of the preterm infant.J Perinatol. 1996 Sep-Oct;16(5):390-6. J Perinatol. 1996. PMID: 8915940 Review.
-
Use of antenatal corticosteroids for fetal maturation in preterm infants.Am Fam Physician. 1997 Sep 15;56(4):1093-6. Am Fam Physician. 1997. PMID: 9310061 Review.
Cited by
-
Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage.Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD000229. doi: 10.1002/14651858.CD000229.pub2. Cochrane Database Syst Rev. 2010. PMID: 20091505 Free PMC article.
-
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.Cochrane Database Syst Rev. 2020 Dec 25;12(12):CD004454. doi: 10.1002/14651858.CD004454.pub4. Cochrane Database Syst Rev. 2020. PMID: 33368142 Free PMC article.
-
Antenatal steroid as an independent risk factor for vitamin K2 deficiency in newborns: A Chinese single-center, retrospective study.Saudi Med J. 2023 Aug;44(8):788-794. doi: 10.15537/smj.2023.44.8.20230084. Saudi Med J. 2023. PMID: 37582573 Free PMC article.
-
The effects of antenatal corticosteroid treatment on IVH-PVh of premature infants.Bosn J Basic Med Sci. 2008 Feb;8(1):58-62. doi: 10.17305/bjbms.2008.2999. Bosn J Basic Med Sci. 2008. PMID: 18318674 Free PMC article. Clinical Trial.
-
Vitamin K supplementation during pregnancy for improving outcomes: a systematic review and meta-analysis.Sci Rep. 2018 Jul 30;8(1):11459. doi: 10.1038/s41598-018-29616-y. Sci Rep. 2018. PMID: 30061633 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical